Morning Market Losers
July 28, 2015 at 09:51 AM EDT
Immunomedics, Inc. (NASDAQ: IMMU) tumbled 46.63 percent to $1.98 following news from the company's licensing partner UCB that Phase ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.